pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
af3db7f2-1c0a-420e-a4bb-16d70fe0eb72
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-17 18:43:29
Income (reported)
$20,000
Expenses (reported)
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

MEHLMAN CONSULTING, INC.

Government Affairs Consulting Services

Contact
SOLVEIG MONSON
Phone
+1 202-585-0292
Address
zip:20005, city:WASHINGTON, state:DC, street:1341 G Street, NW Suite 1100

Client

WEDGEWOOD PHARMACY LLC

U.S. compounding pharmacy devoted to animal health

State
NJ
Country
US
Government-entity client
false
Effective date
2021-03-01

Issues lobbied + lobbyists

PHA — Pharmacy

Issues related to animal drug compounding.

Lobbyists: BRUCE MEHLMAN; DEAN ROSEN; SAGE EASTMAN; mr DAVID R THOMAS; ELISE FINLEY PICKERING; LAUREN ARONSON; MICHAEL ROBINSON; HELEN TOLAR; NICHOLE DISTEFANO; PAUL THORNELL; STEPHEN M. COTE; ALEXANDER PERKINS; ROSEMARY GUTIERREZ; ZACHARY MALLOVE; CAITLIN VAN SANT; LISA GOLDMAN; ALYENE MLINAR; ms ERICA JAY CHABOT; ANNIE WOLF; NAVEEN PARMAR; JON ADAME; mr JOSEPH EDWARD BROWN iii; EARL SCOTT FLOOD

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

ANI — Animals

Issues related to animal drug compounding.

Lobbyists: BRUCE MEHLMAN; DEAN ROSEN; mr DAVID R THOMAS; ELISE FINLEY PICKERING; SAGE EASTMAN; LAUREN ARONSON; MICHAEL ROBINSON; HELEN TOLAR; NICHOLE DISTEFANO; PAUL THORNELL; STEPHEN M. COTE; ALEXANDER PERKINS; ROSEMARY GUTIERREZ; ZACHARY MALLOVE; CAITLIN VAN SANT; LISA GOLDMAN; ALYENE MLINAR; ms ERICA JAY CHABOT; ANNIE WOLF; NAVEEN PARMAR; JON ADAME; mr JOSEPH EDWARD BROWN iii; EARL SCOTT FLOOD

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.